Differences between patients', physicians' and pharmacists' preferences for treatment products in haemophilia: a discrete choice experiment.
about
Present and future challenges in the treatment of haemophilia: the patient's perspectiveThe evolution of comprehensive haemophilia care in the United States: perspectives from the frontline.Discrete choice experiments of pharmacy services: a systematic review.Uncovered needs in the management of inherited bleeding disorders in Italy.The physician's role in selecting a factor replacement therapy.Quality of life assessment in clinical practice in haemophilia treatment.Haemophilia A: meeting the needs of individual patients.Patients' and urologists' preferences for prostate cancer treatment: a discrete choice experimentAntihemophilic factor (recombinant) plasma/albumin-free method for the management and prevention of bleeding episodes in patients with hemophilia AHaemophilia prophylaxis: how can we justify the costs?Economic evaluations of prophylaxis with clotting factor for people with severe haemophilia: why do the results vary so much?Discrete choice experiments in pharmacy: a review of the literature.Patient preferences versus physicians' judgement: does it make a difference in healthcare decision making?Do patients and health care providers have discordant preferences about which aspects of treatments matter most? Evidence from a systematic review of discrete choice experiments.Physicians' preferences towards coagulation factor concentrates in the treatment of Haemophilia with inhibitors: a discrete choice experiment.Facilitating the implementation of pharmacokinetic-guided dosing of prophylaxis in haemophilia care by discrete choice experiment.Assessment of the impact of treatment on quality of life of patients with haemophilia A at different ages: insights from two clinical trials on turoctocog alfa.Patient and parent preferences for characteristics of prophylactic treatment in hemophilia.Physicians underestimate the importance of patient-centredness to patients: a discrete choice experiment in fertility care.Patient and parent preferences for haemophilia A treatments.Patient benefit-risk preferences for targeted agents in the treatment of renal cell carcinoma.The perspective of patients with haemophilia with inhibitors and their care givers: preferences for treatment characteristics.Preference-based valuation of treatment attributes in haemophilia A using web survey.Physician preferences for medication attributes for the prophylactic treatment of patients with severe haemophilia A with inhibitors to factor VIII.Comparison of preferences of healthcare professionals and MS patients for attributes of disease-modifying drugs: A best-worst scaling.Insights into public preferences for pharmaceutical funding
P2860
Q27022801-BDF3E1AC-1419-4C2E-8830-53E95F900414Q30249256-2039A57C-205C-400A-8C22-8F66F62C0EB0Q30381933-8A3CD785-E238-4335-A745-52E03CC537F9Q33708980-4690A603-C498-41C7-B6D9-4D57245D9DE3Q36381546-9352C292-AD14-43A4-BF81-B715C6956920Q36473028-126D695B-0FAC-482B-A8D8-F8CE8DB640AEQ37008132-796CD516-C95B-431A-8622-E7AE56AA0752Q37081919-0ECF6EF2-66E2-49AA-8B80-ECD2CF3254DEQ37303186-34732CF5-F6CE-41AD-955C-7994411933D0Q38002994-69A08A07-2CEF-4BDC-9DA9-1243B7CBEED6Q38044472-E35CBD0D-A254-4A66-B418-D2DC72B4B3BCQ38072719-6B94B2B0-4869-4529-9662-9D3158022936Q38093110-D8AD6EE0-CE75-466F-94AB-37F4FCD84CE4Q38682667-CEC317B9-5934-4A96-ABE3-17943C4EAF3AQ39323587-CA2E2B83-219E-48B7-8257-274A2C55E238Q40268971-736C1E49-EE77-4BF4-99FC-1DB1066EDB62Q43088590-272E9D8E-A09B-40D7-91F0-298FAD29EEC3Q43148985-B4E07227-0F65-40D0-8107-7F5530FC4087Q44204137-B3ED8DDE-6889-4DD7-86C8-3F87BCED726FQ44511279-BE8E4B4A-E826-4F53-94A9-12C7F8E989A2Q44833336-A0A347A6-571F-48CF-82D4-DCBC17D5DD33Q45865143-F56C6CB0-BAE5-4135-A023-C195CE27294FQ45871318-83C626E9-7268-40EE-8F35-5C69D82E2090Q45882018-0F848FEA-2D69-4A4F-9CBA-5B8AFEAB2CF8Q47663169-F0E22B4C-AEEF-47BD-B48F-77F6E442CBB8Q57574361-F2AC7BE8-A57A-44E7-836C-194E31910E03
P2860
Differences between patients', physicians' and pharmacists' preferences for treatment products in haemophilia: a discrete choice experiment.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Differences between patients', ...... a discrete choice experiment.
@en
Differences between patients', ...... a discrete choice experiment.
@nl
type
label
Differences between patients', ...... a discrete choice experiment.
@en
Differences between patients', ...... a discrete choice experiment.
@nl
prefLabel
Differences between patients', ...... a discrete choice experiment.
@en
Differences between patients', ...... a discrete choice experiment.
@nl
P2093
P2860
P1433
P1476
Differences between patients', ...... a discrete choice experiment.
@en
P2093
A Gringeri
Conan Study Group
M S Monzini
P M Mannucci
P2860
P304
P356
10.1111/J.1365-2516.2005.01159.X
P577
2005-11-01T00:00:00Z